92 related articles for article (PubMed ID: 1370316)
1. The in vitro radiosensitivity of lymphocytes from chronic lymphocytic leukaemia using the differential staining cytotoxicity (DiSC) assay. I--Investigation of the method.
Hinkley HJ; Bosanquet AG
Int J Radiat Biol; 1992 Jan; 61(1):103-10. PubMed ID: 1370316
[TBL] [Abstract][Full Text] [Related]
2. The in vitro radiosensitivity of lymphocytes from chronic lymphocytic leukaemia using the differential staining cytotoxicity (DiSC) assay. II--Results on 40 patients.
Hinkley HJ; Bosanquet AG
Int J Radiat Biol; 1992 Jan; 61(1):111-21. PubMed ID: 1370317
[TBL] [Abstract][Full Text] [Related]
3. Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology.
Bosanquet AG; Bell PB
Leuk Res; 1996 Feb; 20(2):143-53. PubMed ID: 8628013
[TBL] [Abstract][Full Text] [Related]
4. Simplified quantitative estimation in vitro of lymphocyte radiosensitivity applied to patients with chronic lymphocytic leukaemia.
Thomson AE; Wetherley-Mein G; O'Connor TW; Still B; Peel WE; Slater NG; Bates T
Leuk Res; 1991; 15(7):577-89. PubMed ID: 1861541
[TBL] [Abstract][Full Text] [Related]
5. An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.
Bosanquet AG; Bird MC; Price WJ; Gilby ED
Br J Cancer; 1983 Jun; 47(6):781-9. PubMed ID: 6190492
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of chronic lymphocytic leukaemia lymphocytes to irradiation in vitro.
Bentley P; Salter R; Blackmore J; Whittaker JA; Hanson JA; Champion AR
Leuk Res; 1995 Dec; 19(12):985-8. PubMed ID: 8632669
[TBL] [Abstract][Full Text] [Related]
7. Relationship between in vitro and in vivo radiosensitivity of lymphocytes in chronic lymphocytic leukemia.
Schrek R; Best WR; Stefani S
Acta Haematol; 1988; 80(3):129-33. PubMed ID: 3143211
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity.
Pu QQ; Bezwoda WR
Br J Haematol; 1997 Aug; 98(2):413-7. PubMed ID: 9266941
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia lymphocytes lack the capacity to repair UVC-induced lesions.
Tuck A; Smith S; Larcom L
Mutat Res; 2000 Feb; 459(1):73-80. PubMed ID: 10677685
[TBL] [Abstract][Full Text] [Related]
10. Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay.
Bosanquet AG; Johnson SA; Richards SM
Br J Haematol; 1999 Jul; 106(1):71-7. PubMed ID: 10444165
[TBL] [Abstract][Full Text] [Related]
11. Idelalisib may have the potential to increase radiotherapy side effects.
Gryc T; Putz F; Goerig N; Ziegler S; Fietkau R; Distel LV; Schuster B
Radiat Oncol; 2017 Jun; 12(1):109. PubMed ID: 28659152
[TBL] [Abstract][Full Text] [Related]
12. In vitro assay for the quantitative measurement of apoptotic lymphocytes phagocytosis by peripheral blood monocytes.
Popovic S; Arsenijevic N; Baskic D
Acta Physiol Hung; 2006 Dec; 93(4):325-33. PubMed ID: 17191664
[TBL] [Abstract][Full Text] [Related]
13. Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies.
Bird MC; Bosanquet AG; Forskitt S; Gilby ED
Leuk Res; 1986; 10(4):445-9. PubMed ID: 2421109
[TBL] [Abstract][Full Text] [Related]
14. Differences between responsive and intractable chronic lymphocytic leukemia.
Schrek R
Med Hypotheses; 1990 Feb; 31(2):81-2. PubMed ID: 2325590
[TBL] [Abstract][Full Text] [Related]
15. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
Guillaume N; Alimardani G; Capiod JC; Claisse JF
Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.
Vandenbulcke K; De Vos F; Offner F; Philippé J; Apostolidis C; Molinet R; Nikula TK; Bacher K; de Gelder V; Vral A; Lahorte C; Thierens H; Dierckx RA; Slegers G
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1357-64. PubMed ID: 12845484
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Bosanquet AG; McCann SR; Crotty GM; Mills MJ; Catovsky D
Acta Haematol; 1995; 93(2-4):73-9. PubMed ID: 7543720
[TBL] [Abstract][Full Text] [Related]
18. The intrinsic radiosensitivity of lymphocytes in chronic lymphocytic leukaemia, quantitatively determined independently of cell death rate factors.
Thomson AE; Vaughan-Smith S; Peel WE; Wetherley-Mein G
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Dec; 48(6):943-61. PubMed ID: 3877700
[TBL] [Abstract][Full Text] [Related]
19. Effects of hyperthermia on radiosensitivity of normal and leukaemic lymphocytes.
Schrek R; Stefani SS
Br J Exp Pathol; 1980 Jun; 61(3):256-60. PubMed ID: 7426381
[TBL] [Abstract][Full Text] [Related]
20. Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
Ganeshaguru K; Wickremasinghe RG; Jones DT; Gordon M; Hart SM; Virchis AE; Prentice HG; Hoffbrand AV; Man A; Champain K; Csermak K; Mehta AB
Haematologica; 2002 Feb; 87(2):167-76. PubMed ID: 11836167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
